Uncategorized Archives - Page 77 of 87 - PsychedelicNewsWire (PNW)

MondayApr 15, 2019 12:14 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Advancing DehydraTECH Drug Delivery Platform, Innovative Products

Lexaria Bioscience is focusing on its pioneering DehydraTECH drug delivery technology The company boasts a portfolio of unique products Lexaria continues to conduct research regarding DehydraTECH technology for oral nicotine Based in Kelowna, British Columbia, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Lexaria is the only global company with patents issued for the oral delivery of all cannabinoids. The company has developed and out-licenses its innovative and cost-effective DehydraTECH drug delivery platform. This technology changes the way that edible cannabinoids enter the body. DehydraTECH delivery technology offers a viable and…

TuesdayApr 09, 2019 10:32 am

VPR Brands, LP (VPRB) is “One to Watch”

Diversified product lines, new sales channels and distributors, an expanded sales team, and increasing social awareness of VPR Brands has increased profit margins GoldLine CBD product division increases target market and potential customers in the consumable supplements and nutraceuticals sectors Cutting-edge technology and user-centric designs uniquely engineered to be used with cannabis or CBD oils, concentrates and flowers Private label (white label) business is a growth sector; in 2018 VPR Brands white labeled several award-winning vaporizers for prominent companies Required testing and certification to allow all VPR Brand products to be imported and sold in the European Union is underway…

TuesdayMar 26, 2019 11:56 am

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Revolutionary Technology is Disrupting the Cannabis Edibles Industry

Lexaria Bioscience Corp. is the only company worldwide with patents issued for oral delivery of all cannabinoids Its proprietary technology bests traditional methods such as inhalation in several key ways The company continues to enhance its intellectual property portfolio as it pursues patents around the world Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a food biosciences company, has developed a proprietary technology that has revolutionized the way cannabidiol (CBD) and other non-psychoactive cannabinoids are delivered into the bloodstream. Lexaria, the only company worldwide with patents issued for oral delivery of all cannabinoids, has greatly improved the delivery of bioactive compounds.…

TuesdayMar 12, 2019 12:31 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Innovating on Numerous Fronts with DehydraTECH Drug Delivery Platform

Lexaria Bioscience is focusing on its unique technology for the delivery of bioactive compounds The company’s concentration on oral ingestion results in an option that often healthier than other delivery methods Its DehydraTECH technology has potential applications for nicotine absorption Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) focuses on technology for the improved delivery of bioactive compounds. Its DehydraTECH drug delivery platform fosters healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. The company’s process changes the way edible cannabinoids enter the body (http://cnw.fm/s5uPI). A drug delivery innovator, Lexaria Bioscience is headquartered in Kelowna,…

FridayMar 01, 2019 12:53 pm

The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Does Not Irradiate its Cannabis; 80 Percent of LPs Do

Clean, controlled cultivation eschews use of radiation to destroy pests and pathogens Analysts at Jefferies recently initiated coverage of FLWR Flowr has applied for Nasdaq Listing The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is growing cannabis with TLC as well as THC. The Health Canada Licensed Producer (“LP”) of cannabis, founded by MedReleaf co-founder Tom Flow and a team of industry pioneers, is out to generate premium, non-irradiated product at high yields. The company expects its ability to produce clean cannabis at consistently high quality to be a crucial differentiating factor as the medical and recreational markets in Canada develop. Its…

FridayMar 01, 2019 11:13 am

Marijuana Company of America Inc.’s (MCOA) High-Yielding Hemp Projects Blossom as ‘Green Industry’ Set to Thrive in 2019

Global hemp retail sales totaled $3.7 billion in 2018, on track to reach $5.7 billion by 2020 2018 Farm Bill legalizing hemp, CBD-based products, now allows farmers to plant industrial hemp nationwide Cultivation of hemp at Scio, Oregon, project site to begin in early 2019 for an extended growing season MCOA’s wholly owned subsidiary, hempSMART, brings high quality, branded CBD-based products to consumers through an affiliate marketing program Market opportunities for the hemp-based cannabidiol (“CBD”) product industry in the U.S. are many and growing now that hemp is legally protected following passage of the 2018 Farm Bill in December. Innovative…

ThursdayFeb 14, 2019 1:53 pm

Marijuana Company of America Inc. (MCOA) Promotes Brand During Super Bowl and Hollywood Events

February events have and will continue to provide the company with opportunities to increase its recognition amid Super Bowl and pre-Academy Awards gatherings Marijuana Company of America Inc. upgraded its market tier to the OTCQB Venture Exchange in December The company is aggressively pursuing a strategy of building a following for its hemp products by marketing to celebrities and pro athletes Amid the rise of the cannabis industry and the high degree of attention that consumers and investors alike are paying to the varied applications of the plant and its derivatives, Marijuana Company of America Inc. (OTCQB: MCOA) is raising…

MondayFeb 11, 2019 11:21 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Creates Unique Opportunity in Global Cannabis Industry

Big corporations are investing in the cannabis industry Major tobacco company provides financing for LXRP LXRP boasts revenue streams within the nicotine industry and opportunity in other sectors Lexaria is a unique company doing business on its own terms The cannabis industry is experiencing impressive growth thanks to both legal and social changes worldwide, and big corporations are stepping up to invest. In a new Audio Press Release (“APR”), PsychedelicNewsAudio praised Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (http://cnw.fm/Ap2N5) for building a large funding deal on its own terms. The APR, ‘Outside Investment, New Technology Support Growing Cannabis Industry’, highlighted Lexaria’s ability…

ThursdayJan 24, 2019 11:37 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Acquires a $12 Million Investor

Lexaria Nicotine LLC partners with one of the world’s largest tobacco companies Opportunity to change nicotine delivery and improve the lives of millions Retains ownership of DehydraTECH while licensing the technology out to multiple industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) recently announced that its wholly owned subsidiary, Lexaria Nicotine LLC, has partnered with one of the world’s largest tobacco companies to fund the research and development of Lexaria’s patented DehydraTECH (http://cnw.fm/w86Vf). The partnership may potentially commercialize this cutting-edge technology for oral nicotine delivery. Chris Bunka, CEO of Lexaria Bioscience, is excited about the opportunity to work with a world-class…

FridayJan 11, 2019 11:10 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Discusses Company Initiatives at O’Cannabiz 2018

Lexaria Bioscience has its innovative DehydraTECH drug delivery platform The company’s DehydraTECH technology is complementary to other R&D being done on cannabinoids Lexaria recently attended O’Cannabiz 2018 in Vancouver A biotech company, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) offers a unique platform that makes it possible to deliver bioactive substances through oral ingestion. Its DehydraTECH technology accomplishes this without the need for unhealthy inhalational dosing. DehydraTECH uses only GRAS (Generally Recognized as Safe) ingredients and increases bio-absorption by five to 10 times. Based in Kelowna, British Columbia, Lexaria Bioscience is the only company globally with patents issued for the…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Uncategorized